HCSGHealthcare Services Group, Inc.
Is the price fair?
Undemanding: modest expectations priced in and cheap against its own history.
Priced for a decline (~−2% a year). The price demands less than its three-year revenue growth of 4% a year, expectations look modest.
Cheap vs its own history: P/E 12.0 vs a 25.4 median over 41 quarters (−53% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What HCSG's price assumes
Healthcare Services Group, Inc. trades at 12.0× earnings against 20.0× for the median Medical Care Facilities name, cheaper than its own group.
Trailing P/E · Medical Care Facilities median 20.0 · cheaper than the typical name in its group
- Price / sales
- 0.89
Price / sales · as of 2026-Q2
- Free cash flow yield
- 9.2%
Free cash flow yield · Medical Care Facilities median 7.1%
- Growth the price implies
- −2.4%
Growth the price implies · The price pays for −2.4% free cash flow growth a year for a decade; revenue has grown +3.6% a year over the last three.
Details›
- Price / bookas of 2026-Q2
- 3.18
- Healthcare median P/E509 names
- 26.2
- Medical Care Facilities median P/E33 names
- 20.0
- Free cash flow, trailing twelve months
- $149M
- Market capitalisation
- $1.62B
- 3-year revenue growth
- +3.6%
| Method | Per share |
|---|---|
| What its own history would imply | not meaningful, 12.0× today against a 25.4× median |
| 52-week range | $15.18 – $25.32 |
| Today | $20.59 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.